Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

While it's often narratives rather than numbers that cause stocks to swing in value, sometimes the most parsimonious way to summarize a company's strengths and weaknesses is to focus on a key quantitative metric or two. Numbers never tell the whole story, but they can often give investors some pretty solid hints about what's coming next.

This 1 Metric Shows Why You Should Be Cautious With Tilray Brands Stock

Tilray Inc (NASDAQ: TLRY) chief executive Irwin Simon expects the recreational use of cannabis to be legalised on a federal level under Donald Trump as the President of the United States. In other words, he expects legalisation to occur over the next four years.

Tilray stock faces challenges despite potential Trump 2.0 cannabis legalization

It's not a secret: The cannabis industry has been a major disappointment since Canada legalized recreational use in 2018. Some companies in the industry diversified away from their cannabis operations as a result.

Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy?

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $1.16, marking no change from the previous day.

Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should Know

ATLANTA, Dec. 19, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company ( “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY and TSX: TLRY) celebrates its 28th year with legendary electronic jam band STS9 which will headline SweetWater's Anniversary Party at its Atlanta brewery on Saturday, February 22. Founded in 1997, SweetWater brought hops to the South and sparked Atlanta's craft beer renaissance.

SweetWater Brewing Announces 28th Anniversary Bash With STS9 Headlining an Immersive Jamtronica Experience

Aurora Cannabis

The global cannabis market tells a tale of survival and adaptation. After a brutal multiyear shakeout that saw dozens of companies fold or merge, the remaining players have emerged battle-tested and strategically transformed.

Better Marijuana Stock: Aurora Cannabis or Tilray Brands?

NEW YORK and LEAMINGTON, Ontario, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the second quarter ended November 30, 2024 before the financial market opens on January 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 a.m.

Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025

Canopy Growth

Village Farms International

Marijuana stock investors are always looking for the next opportunity. Whether short or long-term gains the goal is to make money. The cannabis industry has seen its fair share of volatility both in the legal market and public sector. Even with how things are now there are many ways to enter the market. Cannabis has been on an uptrend in popularity and growing consumer demand.

Top Marijuana Stocks For Investors 2025

Tilray Brands stock price has been in a strong downward trend this year and is now sitting near its all-time low as concerns about the cannabis industry remains. It has imploded by over 48% this year, bringing its valuation to about $1 billion.

Tilray Brands stock price has crashed: time to buy the dip?

TLRY's innovation efforts are quite on track, with the launch of Herb & Bloom, which is a line of cocktail-inspired ready-to-drink, alcohol-free effervescent beverages.

Tilray Brands Introduces Herb & Bloom Non-Alcoholic Beverage

TORONTO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, announced that its Good Supply cannabis brand is launching a new product lineup just in time for the holidays. Good Supply's holiday release celebrates the expansion of its fan-favourite product lines across Canada and includes new, high-potency formats crafted for cannabis enthusiasts looking for potent, flavourful, and affordable experiences.

Unwrap the Ultimate Holiday Experience with Good Supply's Flavour-Packed Innovations

In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $1.26, indicating a -1.56% shift from the previous trading day.

Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts

XMG and Mollo invite consumers to explore a new tradition with their holiday lineup, featuring unique cannabinoid combinations and premium formulations.

Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations

Tilray Brands, Inc. (TLRY) closed at $1.28 in the latest trading session, marking a -1.54% move from the prior day.

Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade

One of the starkest examples of the marijuana industry's struggles is the trajectory of one of its flagship stocks, Tilray (TLRY -2.98%).

If You'd Invested $1,000 in Tilray Stock 6 Years Ago, Here's How Much You'd Have Today

Marijuana legalization doesn't appear to be on the horizon anytime soon. And as a result of the lack of excitement in the industry, many cannabis stocks are struggling, badly.

Down 40% This Year, Is Tilray Brands Stock Due for a Much Better Performance in 2025?

SNDL Inc.

The cannabis sector recently experienced a pullback after Florida voters did not pass recreational cannabis legalization. This has caused a temporary market dip, creating potential entry points for well-researched investors. Despite setbacks, the U.S. cannabis industry continues to expand. It generated $32 billion in sales in 2023 and is expected to surpass $50 billion by 2030. Federal legalization remains a critical catalyst, with Congress debating key reform bills. The SAFE Banking Act and the potential rescheduling of cannabis under the Controlled Substances Act have dominated recent headlines. Investors should stay informed about these developments to understand their market impact.

Best Canadian Cannabis Stocks for Your December 2024 Watchlist

Agrify

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

OrganiGram Holdings Inc.

With cannabis stocks showing steep losses this year on stalled legalization on the U.S. federal level, some companies in the sector are turning to the more thinly-regulated business of THC derived from hemp as a way to potentially excite Wall Street with new revenue streams.

Hemp-based THC revenue may make cannabis stocks more appealing—but there are risks

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.37, denoting a +0.74% change from the preceding trading day.

Why the Market Dipped But Tilray Brands, Inc. (TLRY) Gained Today

Cronos Group

What are marijuana stock investors searching for this holiday season? For starters, some companies have recently reported strong quarterly earnings. The better a company performs, the more intriguing it looks to people to invest in it. Right now, many cannabis companies are making headway outside of the public sector. For instance, there has been a rapid expansion of dispensaries opening across the United States.

3 Marijuana Stocks For Your Holiday Trading

Tilray Brands (TLRY -4.22%) shares still aren't delivering on what investors may have hoped for, falling by 25% during the past 12 months. But, with a few catalysts in play, and with more operational improvements, anything is possible, and hope springs eternal.

Is Tilray Brands Stock a Buy?

Craft flower enthusiasts can now experience the handcrafted excellence and superior genetics of Broken Coast cannabis' latest release: Platinum Pavé.

The Broken Coast Difference: Tilray Brands' Broken Coast Craft Cannabis Introduces New Premium Strain ‘Platinum Pavé'

The outcome of elections can shape policies and decisions for years to come, and it's no exception in the U.S. Following Donald Trump's election as the 47th president of the United States and Republicans gaining control of the Senate and the House of Representatives, some companies and industries could potentially benefit from the change in administration at the national level. Others, not so much.

1 Stock to Avoid After the Election Results

Canada's Tilray Brands built itself into one of biggest craft brewers in U.S.—“I'm either real smart or real dumb,” its CEO said.

This Cannabis Company Is Snapping Up America's Craft Beer Brewers

A hands-off policy on cannabis will be a bad outcome for a business already struggling with ambiguous laws.

News for Tilray Brands Stock (TLRY)